Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies

Go back to Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies
Baxter International Inc. (NYSE: BAX) Delayed: 24.76 +0.41 (1.68%)
Previous Close $24.35    52 Week High $50.16 
Open $24.44    52 Week Low $34.06 
Day High $24.78    P/E 6.77 
Day Low $24.34    EPS $3.66 
Volume 2,001,444